Literature DB >> 6357146

Effectiveness of modified steroid-antibiotic therapies for lethal sepsis in the dog.

B K Beller, L T Archer, R B Passey, D J Flournoy, L B Hinshaw.   

Abstract

Dogs permanently recover (survive at least seven days) from lethal doses of Escherichia coli when treated early with intravenous (IV) intermittent infusions of methylprednisolone sodium succinate and gentamicin sulfate. We evaluated the therapeutic effectiveness of constant or bolus IV infusion of methylprednisolone combined with gentamicin or netilmicin sulfate. Four groups of anesthetized dogs were infused for one hour with E coli and treated as follows (% survival indicated): no treatment (0%); constant infusion of methylprednisolone and gentamicin (100%); bolus infusion of methylprednisolone and gentamicin (57%); and constant infusion of methylprednisolone and netilmicin (83%). Constant or bolus infusion of methylprednisolone was begun 15 minutes after E coli infusion was started. Gentamicin or netilmicin administration was begun when all organisms had been infused. The probability of recovery from shock was significantly increased when dogs were treated with constant infusion of methylprednisolone and intermittent infusions of gentamicin or netilmicin, but was only moderately increased when treated with intermittent bolus infusions of methylprednisolone and intermittent infusions of gentamicin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6357146     DOI: 10.1001/archsurg.1983.01390110045011

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  5 in total

Review 1.  Scientific and clinical challenges in sepsis.

Authors:  Luis Ulloa; Michael Brunner; Laura Ramos; Edwin A Deitch
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 2.  Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.

Authors:  Peter De Paepe; Frans M Belpaire; Walter A Buylaert
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Treatment of bacteremia.

Authors:  J N Sheagren
Journal:  West J Med       Date:  1986-02

Review 4.  Increasing the efficacy of anti-inflammatory agents used in the treatment of sepsis.

Authors:  P Minneci; K Deans; C Natanson; P Q Eichacker
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-01-28       Impact factor: 3.267

5.  Treatment of LD100 Escherichia coli septic shock with netilmicin and methylprednisolone in baboons.

Authors:  D J Flournoy; L T Archer; B K Beller; R Passey; L B Hinshaw
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.